Aspen Pharmacare Holdings (APNHF) Income Statement
16 Followers
Aspen Pharmacare Holdings Income Statement
Last quarter (Q4 2026), Aspen Pharmacare Holdings's total revenue was R18.30B, a decrease of 22.36% from the same quarter last year. In Q4, Aspen Pharmacare Holdings's net income was R1.21B. See Aspen Pharmacare Holdings’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Jun 26 | Jun 25 | Jun 24 | Jun 23 | Jun 22 |
|---|---|---|---|---|---|
| R 34.98B | R 43.36B | R 44.71B | R 40.71B | R 38.61B | |
| R 14.10B | R 19.13B | R 19.45B | R 18.41B | R 18.31B | |
| R 8.68B | R 17.69B | R 12.46B | R 9.46B | R 9.47B | |
| Depreciation and Amortization | R 1.92B | R 2.09B | R 1.97B | R 1.79B | R 1.71B |
| R 7.34B | R 3.62B | R 9.91B | R 9.67B | R 10.61B | |
| R 5.42B | R 1.44B | R 7.00B | R 7.82B | R 8.67B | |
| R -5.84B | R -1.56B | R -1.28B | R -1.27B | R -537.00M | |
| R -419.32M | R -123.00M | R 5.71B | R 6.55B | R 8.13B | |
| R 2.66B | R -1.08B | R 4.40B | R 5.23B | R 6.49B | |
| Per Share Metrics | |||||
| Basic EPS | R 5.96 | R -2.44 | R 9.91 | R 11.77 | R 14.32 |
| Diluted EPS | R 5.96 | R -2.44 | R 9.91 | R 11.77 | R 14.32 |
| Weighted Average Shares Outstanding | 444.10M | 444.00M | 444.20M | 444.20M | 453.00M |
| Weighted Average Shares Outstanding (Diluted) | 444.10M | 444.00M | 444.20M | 444.20M | 453.00M |
Currency in ZAR
